Ultragenyx Pharmaceutical Inc (MEX:RARE)
MXN 751.98 0 (0%) Market Cap: 64.70 Bil Enterprise Value: 57.96 Bil PE Ratio: 0 PB Ratio: 23.46 GF Score: 70/100

Q3 2020 Ultragenyx Pharmaceutical Inc Earnings Call Transcript

Oct 27, 2020 / 09:00PM GMT
Release Date Price: MXN1908.5
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Ultragenyx Third Quarter 2020 Financial Results and Corporate Update. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your host, Joshua Higa. Sir, please go ahead.

Joshua Higa
Ultragenyx Pharmaceutical Inc. - Director of IR & Corporate Communications

Good afternoon. And welcome to the Ultragenyx Financial Results and Corporate Conference Call for the Third Quarter 2020. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com. I'm Joshua Higa, Director of Investor Relations. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Camille Bedrosian, Chief Medical Officer; Erik Harris, Chief Commercial Officer; and Mardi Dier, our Chief Financial Officer, who joined the company a couple of weeks ago. Shalini Sharp, Executive Vice President for Finance, is also on and will be available if needed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot